Biohaven Pharma (BHVN) Tops Q2 EPS by 31c
Tweet
Share
E-mail
Get Alerts BHVN Hot Sheet
Join SI Premium – FREE
Biohaven Pharma (NYSE: BHVN) reported Q2 EPS of ($1.63), $0.31 better than the analyst estimate of ($1.94).
For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paramount Global (PARA) Tops Q2 EPS by 480c
- Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c
- Investcorp Credit Management BDC, Inc. (ICMB) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
